Artelo Biosciences, Inc.

NasdaqCM:ARTL Stock Report

Market Cap: US$3.6m

Artelo Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ARTL?
Owner TypeNumber of SharesOwnership Percentage
Institutions22,5870.7%
Individual Insiders26,7260.828%
General Public3,178,38798.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 10 shareholders own 1.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.63%
Gregory Gorgas
20,446US$22.7k0%no data
0.54%
Geode Capital Management, LLC
17,350US$19.3k-12.4%no data
0.16%
Tower Research Capital Europe Limited
5,183US$5.8k-11%no data
0.12%
Connie Matsui
3,778US$4.2k0%no data
0.026%
Robert Emanuele
834US$925.80%no data
0.026%
Steven Kelly
834US$925.80%no data
0.026%
Douglas Blayney
834US$925.80%no data
0.00081%
Bank of America Corporation, Asset Management Arm
26US$29.00%no data
0.00062%
Morgan Stanley, Investment Banking and Brokerage Investments
20US$22.20%no data
0.00025%
Rothschild Investment LLC
8US$9.00%no data